Vedere Bio II Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.